Quantitative alleles of CR1: Coding sequence analysis and comparison of haplotypes in two ethnic groups

Journal of Immunology

Volumn 163, Issue 9, 1999, Pages 4939-4945

  Xiang, Lianbin ^a   Rundles, Jennifer R ^b   Hamilton, Derrick R ^b   Wilson, James G ^a,c  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b TOUGALOO COLLEGE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; DNA SEQUENCE; ETHNIC GROUP; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEQUENCE ANALYSIS;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; AMINO ACID SUBSTITUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; HAPLOTYPES; HUMANS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, COMPLEMENT 3B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0032754037     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Fearon, D. T., L. B. Klickstein, W. W. Wong, J. G. Wilson, F. D. Moore, Jr., J. J. Weis, J. H. Weis, R. M. Jack, R. H. Carter, and J. A. Ahearn. 1989. Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21). In Biochemistry of the Acute Allergic Reactions: Fifth International Symposium. Liss, New York, p. 211.
2. Hourcade, D., V. M. Holers, and J. P. Atkinson. 1989. The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 45:381.
3. Schifferli, J. A., and R. P. Taylor. 1989. Physiological and pathological aspects of circulating immune complexes. Kidney Int. 35:993.
4. Klickstein, L. B., S. F. Barbashov, T. Liu, R. M. Jack, and A. Nicholson-Weller. 1997. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 7:345.
5. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
6. Müller-Eberhard, H. J. 1992. Complement: chemistry and pathways. In Inflammation: Basic Principles and Clinical Correlates, 2nd Ed. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven, New York, p. 33.
7. Cornacoff, J. B., L. A. Hebert, W. L. Smead, M. E. VanAman, D. J. Birmingham, and F. J. Waxman. 1983. Primate erythrocyte immune complex clearing mechanism. J. Clin. Invest. 71:236.
8. Lobatto, S., M. R. Daha, A. A. Voetman, J. H. Evers-Schouten, A. A. Van Es, E. K. J. Pauwels, and L. A. Van Es. 1987. Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees. Clin. Exp. Immunol. 68:133.
9. Schifferli, J. A., Y. C. Ng, J. Estreicher, and M. J. Walport. 1988. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. J. Immunol. 140:899.
10. Davies, K. A., A. M. Peters, H. L. C. Beynon, and M. J. Walport. 1992. Immune complex processing in patients with systemic lupus erythematosus: in vivo imaging and clearance studies. J. Clin. Invest. 90:2075.
11. Wilson, J. G., E. E. Murphy, W. W. Wong, L. B. Klickstein, J. H. Weis, and D. T. Fearon. 1986. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J. Exp. Med. 164:50.
12. Moldenhauer, J. D., A. H. L. Fielder, P. J. Lachman, and M. J. Walport. 1987. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus. Arthritis Rheum. 30:961.
13. Cohen, J. H. M., V. Caudwell, M. Levi-Strauss, P. Bourgeois, and M. D. Kazatchkine. 1989. Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus. Arthritis Rheum, 32:393.
14. Kumar, A., S. Sinha, P. S. Khandekar, K. Banerjee, and L. M. Srivastava. 1995. HindIII genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon. Immunol. Cell Biol. 73:457.
15. Herrera, A. H., L. Xiang, S. G. Martin, J. Lewis, and J. G. Wilson. 1998. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin. Immunol. Immunopathol. 87:176.
16. Ripoche, J., and R. B. Sim. 1986. Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Biochem. J. 235:815.
17. Barbosa, J. E., R. A. Harrison, P. J. Barker, and P. J. Lachmann. 1992. An anti-peptide antibody that recognizes a neo-antigen in the CR1 stump remaining on erythrocytes after proteolysis. Clin. Exp. Immunol. 87:144.
18. Pascual, M., C. Danielsson, G. Steiger, and J. A. Schifferli. 1994. Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS. Eur. J. Immunol. 24:702.
19. Walport, M. J., and P. J. Lachmann. 1988. Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases. Arthritis Rheum. 31:153.
20. Moldenhauer, F., M. Botto, and M. J. Walport. 1988. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms. Clin. Exp. Immunol. 72:74.
21. Cohen, J. H. M., H. U. Lutz, J. L. Pennaforte, A. Bouchard, and M. D. Kazatchkine. 1992. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 87:422.
22. Bessis, M. 1958. L'Ìlot érythroblastique, unité fonctionnelle de la moelle osseuse. Rev. Hématol. 13:8.
23. Wilson, J. G., and M. Tavassoli. 1994. Microenvironmental factors involved in the establishment of erythropoiesis in bone marrow. In Molecular, Cellular, and Developmental Biology of Erythropoietin and Erythropoiesis. I. Rich and T. R. J. Lappin, eds. New York Academy of Sciences, New York, p. 271.
24. Paccaud, J.-P., J.-L. Carpentier, and J. A. Schifferli. 1988. Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane. J. Immunol. 141:3889.
25. Madi, N., J.-P. Paccaud, G. Steiger, and J. A. Schifferli. 1991. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1). Clin. Exp. Immunol. 84:9.
26. Taylor, R. P., F. Pocanic, C. Reist, and E. L. Wright. 1991. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes. Clin. Immunol. Immunopathol. 61:143.
27. Klickstein, L. B., W. W. Wong, J. A. Smith, J. H. Weis, J. G. Wilson, and D. T. Fearon. 1987. Human C3b/C4b receptor (CR1): demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristic of C3/C4 binding proteins. J. Exp. Med. 165:1095.
28. Hourcade, D., D. R. Miesner, J. P. Atkinson, and V. M. Holers. 1988. Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1. J. Exp. Med. 168:1255.
29. Klickstein, L. B., T. J. Bartow, V. Miletic, L. D. Rabson, J. A. Smith, and D. T. Fearon. 1988. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J. Exp. Med. 168:1699.
30. Wong, W. W., C. A. Kennedy, E. T. Bonaccio, J. G. Wilson, L. B. Klickstein, J. H. Weis, and D. T. Fearon. 1986. Analysis of multiple restriction fragment length polymorphisms of the gene for the human complement receptor type I: duplication of genomic sequences occurs in association with a high molecular mass receptor allotype. J. Exp. Med. 164:1531.
31. Wong, W. W., J. M. Cahill, M. D. Rosen, C. A. Kennedy, E. T. Bonaccio, M. J. Morris, J. G. Wilson, L. B. Klickstein, and D. T. Fearon. 1989. Structure of the human CR1 gene: molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele. J. Exp. Med. 169:847.
32. Vik, D. P., and W. W. Wong. 1993. Structure of the gene for the F allele of complement receptor type 1 and sequence of the coding region unique to the S allele. J. Immunol. 151:6214.
33. Wilson, J. G., W. W. Wong, P. H. Schur, and D. T. Fearon. 1982. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N. Engl. J. Med. 307:981.
34. Changelian, P. S., R. M. Jack, L. A. Collins, and D. T. Fearon. 1985. PMA induces the ligand-independent internalization of CR1 on human neutrophils. J. Immunol. 134:1851.
35. Hourcade, D., D. R. Miesner, C. Bee, W. Zeldes, and J. P. Atkinson. 1990. Duplication and divergence of the amino-terminal coding region of the complement receptor 1 (CR1) gene: an example of concerted (horizontal) evolution within a gene. J. Biol. Chem. 265:974.
36. Cornillet, P., F. Philbert, M. D. Kazatchkine, and J. H. M. Cohen. 1991. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. J. Immunol. Methods 136:193.
37. Chakraborty, R., M. I. Kamboh, M. Nwankwo, and R. E. Ferrell. 1992. Caucasian genes in American blacks: new data. Am. J. Hum. Genet. 50:145.
38. Perkins, S. J., P. I. Haris, R. B. Sim, and D, Chapman. 1988. A study of the structure of human complement component factor H by Fourier transform infrared spectroscopy and secondary structure averaging methods. Biochemistry 27: 4004.
39. 2 chimeric complement inhibitor. J. Exp. Med. 174:1451.
40. Krych, M., R. Hauhart, and J. P. Atkinson. 1998. Structure-function analysis of the active sites of complement receptor type 1. J. Biol. Chem. 273:8623.
41. Krych, M., D. Hourcade, and J. P. Atkinson. 1991. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc. Natl. Acad. Sci. USA 88:4353.
42. Krych, M., L. Clemenza, D. Howdeshell, R. Hauhart, D. Hourcade, and J. P. Atkinson. 1994. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J. Biol. Chem. 269:13273.
43. r complement receptor expressed on chimpanzee erythrocytes. J. Immunol. 153:691.
44. Subramanian, V. B., L. Clemenza, M. Krych, and J. P. Atkinson. 1996. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35): analysis based on ligand binding by chimpanzee erythrocyte complement receptor. J. Immunol. 157:1242.
45. Chevalier, J., and M. D. Kazatchkine. 1989. Distribution in clusters of complement receptor type one (CR1) on human erythrocytes. J. Immunol. 142:2031.
46. Norman, D. G., P. N. Barlow, M. Baron, A. J. Day, R. B. Sim, and I. D. Campbell. 1991. Three-dimensional structure of a complement control protein module in solution. J. Mol. Biol. 219:717.
47. Barlow, P. N., D. G. Norman, A. Steinkasserer, T. J. Horne, J. Pearce, P. C. Driscoll, R. B. Sim, and I. D. Campbell. 1992. Solution structure of the fifth repeat of factor H: a second example of the complement control protein module. Biochemistry 31:3626.
48. Barlow, P. N., M. Baron, D. G. Norman, A. J. Day, A. C. Willis, R. B. Sim, and I. D. Campbell. 1991. Secondary structure of a complement control protein module by two-dimensional H NMR. Biochemistry 30:997.
49. Moulds, J. M., M. W. Nickells, J. J. Moulds, M. C. Brown, and J. P. Atkinson. 1991. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group antisera. J. Exp. Med. 173:1159.
50. Moulds, J. M., J. J. Moulds, M. Brown, and J. P. Atkinson. 1992. Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1. Vox Sang. 62:230.
51. Petty, A. C., C. A. Green, J. Poole, and G. L. Daniels. 1997. Analysis of Knops blood group antigens on CR1 (CD35) by the MAIEA test and by immunoblotting. Transfusion Med. 7:55.
52. Goldstein, D. B., A. R. Linares, L. L. Cavalli-Sforza, and M. W. Feldman. 1995. Genetic absolute dating based on microsatellites and the origin of modern humans. Proc. Natl. Acad. Sci. USA 92:6723.
53. Tishkoff, S. A., E. Dietzsch, W. Speed, A. J. Pakstis, J. R. Kidd, K. Cheung, B. Bonné-Tamir, A. S. Santachiara-Benerecetti, P. Moral, M. Krings, S. Pääbo, E. Watson, N. Risch, T. Jenkins, and K. K. Kidd. 1996. Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science 271:1380.
54. Harding, R. M., S. M. Fullerton, R. C. Griffiths, J. Bond, M. J. Cox, J. A. Schneider, D. S. Moulin, and J. B. Clegg. 1997. Archaic African and Asian lineages in the genetic ancestry of modern humans. Am. J. Hum. Genet. 60:772.
55. Zietkiewicz, E., V. Yotova, M. Jarnik, M. Korab-Laskowska, K. K. Kidd, D. Modiano, R. Scozzari, M. Stoneking, S. Tishkoff, M. Batzer, and D. Labuda. 1998. Genetic structure of the ancestral population of modern humans. J. Mol. Evol. 47:146.
56. Schifferli, J. A., Y. C. Ng, J.-P. Paccaud, and M. J. Walport. 1989. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans. Clin. Exp. Immunol. 75:329.
57. Madi, N., G. Steiger, J. Estreicher, and J. A. Schifferli. 1991. Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 85:373.
58. Wilson, J. G., W. W. Wong, E. E. Murphy, III, P. H. Schur, and D. T. Fearon. 1987. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. J. Immunol. 138:2706.
59. Tebib, J. G., C. Martinez, J. Granados, D. Alarcon-Segovia, and P. H. Schur. 1989. The frequency of complement receptor type 1 (CR1) gene polymorphisms in nine families with multiple cases of systemic lupus erythematosus. Arthritis Rheum. 32:1465.
60. Satoh, H., E. Yokota, K. Tokiyama, T. Kawaguchi, and Y. Niho. 1991. Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1. Ann. Rheum. Dis. 50:765.
61. Rowe, J. A., J. M. Moulds, C. I. Newbold, and L. H. Miller. 1997. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388:292.
62. Ruuska, P. E., I. Ikäheimo, S. Silvennoinen-Kassinen, M.-L. Käär, and A. Tiilikainen. 1992. Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon? Clin. Exp. Immunol. 89:18.